GUBBA PHARMA IN E NEWS

Sun Pharma mulling new manufacturing unit in AP

December 29, 2021 Gubba Pharma In E News

Drug-maker Sun Pharma is planning to set up an integrated end-to-end manufacturing plant in Andhra Pradesh. Dilip Shangvi, MD, Sun Pharma, has called on Chief...

Continue Reading

The Glenmark Nutrition Awards 2021: Celebrating the warriors who fought the hunger pandemic

December 29, 2021 Gubba Pharma In E News

The Glenmark Nutrition Awards was organised in partnership with the UN World Food Programme and Idobro Impact Solutions during the RISE World Summit which was...

Continue Reading

WHO lists 9th COVID-19 vaccine for emergency use with aim to increase access to vaccination in lower-income countries

December 22, 2021 Gubba Pharma In E News

The World Health Organization issued an emergency use listing (EUL) for NVX-CoV2373, expanding the basket of WHO-validated vaccines against the SARS-CoV-2 virus. The vaccine, named...

Continue Reading

Brinton Pharma gets top award for pioneering an impact on Indian industry – Healthcare

December 22, 2021 Gubba Pharma In E News

Rahulkumar Darda, Chairman and Managing Director, Brinton Pharmaceuticals received the coveted “Pioneering an impact on Indian industry – Healthcare” award during the Rise Startup to...

Continue Reading

BDR Pharmaceuticals launches India’s first generic Midostaurin for treatment of Leukemia

December 22, 2021 Gubba Pharma In E News

BDR Pharma, one of India’s leading generic pharmaceutical companies has launched India’s first Generic- Midostaurin under the brand name MSTARIN, which is indicated in rare,...

Continue Reading

World’s first plant-based Covid vaccine a step closer to launch

December 15, 2021 Gubba Pharma In E News

Canadian biotech Medicago and GlaxoSmithKline are pushing for regulatory approval of the world’s first plant-based vaccine after positive results against a number of coronavirus variants...

Continue Reading

J&J Shot Loses Antibody Protection Against Omicron In Study

December 15, 2021 Gubba Pharma In E News

Johnson & Johnson’s vaccine produced virtually no antibody protection against the omicron coronavirus variant in a laboratory experiment, underlining the new strain’s ability to get...

Continue Reading

Zydus Cadila gets USFDA approval to market generic schizophrenia drug

December 15, 2021 Gubba Pharma In E News

Drug firm Zydus Cadila said it has received approval from the US health regulator to market generic drug Cariprazine capsules, which are used in the...

Continue Reading

Lupin announces launch of educational mobile website Sciflix

December 1, 2021 Gubba Pharma In E News

Global pharma major Lupin announced the launch of Sciflix, an educational mobile adaptable website for medical students who are pursuing post-graduation with chest specialisation. Curated...

Continue Reading